HCV Advocate LogoHCV Advocate Logo
Contact Us Site Map Resources en Espanol
For living Positivley. Being Well
About Hepatitis
News Updates
News Review
Conference reports
News Articles
HCV Advocate Newsletter
Sign up for Email Updates
Community & Support
Resource Library
About Hcsp
 
Bookmark and Share
News Review

HCSP News Review

Top News

Journal Review

Eblast

Archives

This section offers reader-friendly interpretations of some of the more complex current events in hepatitis C, including medical and scientific advancements. The following articles have been compiled by Alan Franciscus, founder of HCSP and HCVAdvocate.org.

Read current articles posted below, or visit our News Review Archive to read articles from previous years.

This site includes links to files you can view online or print. To download and print information, you will need the latest version of Adobe Acrobat Reader. Download it free.




EASL 2014 Click Here

EASL 2013 Click Here

AASLD 2013 Click Here

AASLD 2012 Click Here

EASL 2012 Click Here

AASLD 2011 Click Here

EASL 2011 Click Here

Top News 2014

Free Hepatitis C Screenings Offered in Denver, Colorado
May 2

Canada: Alberta warns patients to get tested due to equipment sterilization concerns
May 2

Lucinda Porter, RN conducting an HCSP training workshop in Reading, PA
May 2

Drug Diversion in Health Care Settings Can Put Patients At Risk for Viral Hepatitis
May 2

ACT-First: Free, Online CME Course for Primary Care Providers
May 1

Ex-champ Vertex calls it quits on hep C, concentrates on CF
May 1

Vertex Reports First Quarter 2014 Financial Results and Provides Updates on Key Business Priorities
May 1

Sovaldi and Ledipasvir with and without Ribavirin - 8 & 12 Weeks, by Alan Franciscus
May 1

Australia: Get checked for Hepatitis C and you could be cured. Its that simple!
April 30

FDA reminds health care professionals to stop dispensing prescription combination drug products with more than 325 mg of acetaminophen
April 30

An Emerging Epidemic: the public health response to hepatitis C infection among young people who inject drugs
April 29

Pa. Dept. of Health offers help to patients of Steelton doctor
April 28

Australia: Settlement in Victorian hep C lawsuit
April 28

Living with liver disease – hepatitis C seems to be biting the dust
April 26

Canada: Needle distribution has positive effects: report - Injection drug use on the rise across the province
April 26

India: Robin Hood of the pharma world
April 25

Local Vietnam Veteran Receives 'Miracle Cure'
April 25

MEDIA ADVISORY: Hepatitis C education material re: Rep. Mia Jones amendment to HB 819
April 25

CDC: Infection exposure possible at nontransplant anatomical donation center
April 25

Texas father receives gift of life from son
April 25

Local patients in clinical trials cured of Hepatitis C
April 25

Fighting a Silent Epidemic: Viral Hepatitis in the African American Community
April 24

Congress Presses the VA for Increased Attention to Hepatitis C
April 24

From the duh files: should food workers be vaccinated against Hepatitis A?
April 23

Hepatitis C victim in dental scare writes of fears
April 23

Medical Spotlight: Hepatitis Awareness Month
April 23

Australia: Hepatitis C class action forced to trial after settlement fails
April 23

Letter: 'Shockingly expensive' drug could be a bargain
April 23

Gilead Sciences' hepatitis C drug a smashing success
April 23

Nursing Home Faces Hepatitis C Outbreak
April 22

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
April 22

Hemophilia Patients Urge NIH & IRB To Stop Ineffective Hepatitis C Trial
April 22

Oklahoma Dental Groups Split On Oral Surgery Legislation
April 22

Blood transfusion led to death of Barnstaple woman
April 20

Hepatitis C spiking on Cape
April 20

Hepatitis C: Triple DAA Plus Ribavirin Highly Effective for Genotype 1 Infections
April 17

Wheeling-Ohio County Health Department Concerned Over Illegal Tattoo Operations
April 17

New England Journal of Medicine - Gilead, by Alan Franciscus (epub ahead of print)
April 16

UK: NHS England agrees funding for life-saving hepatitis C drug Sofosbuvir
April 16

Patients with severe telaprevir-related skin eruption can continue treatment
April 16

Senate panel takes up medical registry bill
April 16

Staying Safe Intervention reduced HCV, HIV risk in drug users
April 16

UK: Needle exchange scheme numbers rise 50% in four years
April 16

Louisiana Taking Away Medicaid Lifeline for Disabled, Other Vulnerable Residents
April 16

Chronic Hepatitis C Genotype 4: RESTORE Study Results
April 15

BI rethinks hepatitis business, posts 2013 results
April 15

New England Journal of Medicine - AbbVie, by Alan Franciscus (epub ahead of print)
April 15

Meet the HCV Expert, April 17, 2014: Falls Church VA
April 13

Destigmatizing Hepatitis C
April 13

Texas to Limit Access to New Hepatitis C Drug to Sicker Patients
April 12

New drugs provide cure for hepatitis C, research finds
April 12

Why Hepatitis C Is Vastly Underreported?
April 10

Natco seeks to block Gilead's hepatitis C drug patent in India-source
April 10

INTERVIEW-Gilead aims to license hepatitis C drug to 3-4 Indian firms
April 9

WHO issues first hepatitis C treatment guidelines
April 9

New Treatments May Defuse Viral Time Bomb
April 9

Treating Hepatitis C with a Pill a Day? Seriously? by Lucinda K. Porter, RN
April 8

NHS adviser calls for needle exchanges for steroid users
April 8

Schedule for Hepatitis C Training Workshops: April - May 2014
April 8

Outreach worker offers free testing and help to drug users
April 8

CDC Resources for May & Hepatitis Awareness Month
April 8

Lower Price Hill refuses needle exchange program
April 7

Phase 3 Studies: Sovaldi/Olysio and Sovaldi/Daclatasvir, by Alan Franciscus
April 7

Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection
April 7

Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C
April 7

Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
April 7

Needle exchange marches on after getting the boot
April 5

Hepatitis C advocate seeks PharmaCare coverage for Sovaldi
April 4

WHO to release HCV treatment guidelines
April 4

UC Davis clinical trials — helping revolutionize hepatitis C treatment
April 4

UC doctor frustrated as Springdale tells needle exchange to hit the road
April 4

Updated Viral Hepatitis Action Plan Released
April 4

Coffee consumption reduces mortality risk from liver cirrhosis
April 3

Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line
April 3

Two phase III trials evaluating once-daily Simeprevir and Sofosbuvir in hepatitis C infected patients have been initiated
April 3

The real cost of a cheap tattoo
March 31

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals
March 31

True Champions: Hepatitis C Videos
March 31

Low-dose oral interferon more effective in preventing relapse among HCV patients with mild fibrosis
March 31

Promising new Aussie gene therapy to be tested on hepatitis patients in US
March 31

Hidden risk in one in ten sausages: Hepatitis E in pork could be making tens of thousands ill, say government experts
March 28

SF patients told of disease risk after equipment not fully sterilized
March 28

Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination
March 28

Complications of cirrhosis led to increased mortality risk
March 28

European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Chronic Hepatitis C Infection
March 27

Australia: Eliminating hepatitis C – an ambitious but achievable goal
March 27

Launch of the Updated Viral Hepatitis Action Plan on Thursday, April 3
March 27

The Patient Access Network (PAN) Foundation
March 26

Interferon-free BMS combo cures 90% of genotype 1 hepatitis C
March 26

AHS warns Edmontonians to get tested after tattoo parlour shut down
March 25

Should Prisoners Get Expensive Hepatitis C Drugs?
March 25

Adelaide researchers claim breakthrough in tackling HIV and hepatitis C with DNA vaccine
March 25

Merck to present new data for investigational hepatitis C treatments MK-5172 and MK-8742 at EASL Annual Meeting/The International Liver Congress™ 2014
March 24

Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple Investigational All-oral Combinations across Hepatitis C Genotypes at The International Liver CongressTM
March 24

AbbVie to Present Detailed Results from Phase III Studies in Patients with Chronic Hepatitis C at the 2014 International Liver Congress™
March 24

Medivir: Simeprevir has now been approved in Russia
March 24

Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL)
March 24

Health Group Wants to Give Clean Syringes to Drug Users
March 23

Tulsa dentist accused of unsanitary practices yet to face dentistry board
March 23

U.S. lawmakers want Gilead to explain Sovaldi's hefty price
March 21

Merck combination suppresses HCV in mono-infected and co-infected patients
March 21

J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
March 21

Screening for HCV Before Chemo
March 21

AASLD Endorses Vibration Controlled Transient Elastography
March 20

The battle to free Taunton from heroin's deadly grip
March 20

Shared Medical Appointments and Hepatitis C Update - Health Matters
March 20

Paul Barrere Talks Feat, Fred, Phish and Phil
March 19

Dental patients offered Hepatitis C test after infection probe
March 19

Action Alert! Urge Your House Representative To Sign Important Dear Colleague Letter
March 19

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy
March 17

New Phase III Data from Once-Daily Simeprevir Presented at the Conference of the Asian Pacific Association for the Study of the Liver (APASL)
March 17

Prisons grapple with tattoo problem
March 17

This Program Would Save Heroin Addicts' Lives, Help Curb Disease And Save Money
March 17

Dirty needles suspected in hepatitis C spread
March 17

Happy to be in the local picture
March 17

New Hep C drugs must be affordable worldwide, say campaigners
March 17

Good news for HIV patients with latest Hep C treatments
March 16

New treatments promise a future free from hep C
March 16

Australia: Alarming increase in Hep C deaths among baby boomers
March 14

Free Hepatitis C screening and walk at Lake Merritt, Saturday March 15, 2014
March 14

Acupuncture Is Associated with Less Chronic Pain Outcomes Compared with No Acupuncture
March 14

Hepatitis C Patients May Get Triaged For New Cures Based On Amount of Liver Damage
March 14

Idenix files lawsuits in Europe, charging Gilead infringed on its patent by marketing hep C drug
March 14

Conn. bill: Hepatitis C screening for baby boomers
March 14

Canada: Petition seeking access to new hepatitis C drugs nears 64,000 signatures
March 13

NKY health officials concerned about hepatitis C linked to heroin use
March 13

Responding to the escalating impact of viral hepatitis in Asia Pacific
March 13

Gene variants protect against relapse after treatment for hepatitis C
March 13

Proposed Testing for Hepatitis C Prompts Debate in Medical Community
March 13

Why Aren't Doctors Drug Tested?
March 12

Experimental drugs offer hope for people with hepatitis C
March 12

Hepatitis C Treatment: Proceed Now or Wait? by Lucinda K. Porter, RN
March 12

Long Island Hospital Says Patients May Be at Risk of Infection to Hepatitis, HIV
March 11

NJ life: Rockers rush to aid ailing Jefferson Starship guitarist
March 11

HCV in Women – Long Term Follow-up
March 10

Merck's Investigational Hepatitis C Treatment Regimen MK-5172/MK-8742 Shows Robust Anti-HCV Activity in HIV/HCV Co-Infected Patients with HCV Genotype 1 Infection
March 10

Creating a media channel to fight Hepatitis C
March 10

Experts: Fewer survive hepatitis C
March 9

Hepatitis C medicines must be made accessible faster than HIV drugs were
March 7

What's in a Name?
March 6

Omega-3 Fatty Acids: A New Approach to HCV Treatment-Related Depression
March 6

Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-Infected Patients Treated with Faldaprevir
March 6

Great news: Draft Medicare Hepatitis C Testing Proposal
March 5

Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection
March 5

CROI: New hep C regimen of just six weeks in length cures nearly everyone in hard to treat population
March 5

HIV No Bar to HCV Therapy With New Agents
March 4

Brief Overview of HCV Drug Data (DAA's) Released at CROI 2014—March 4, 2014
March 4

Genotype 3: Disease Progression
March 4

SVR12 results from a phase IIa study evaluating Simeprevir and Daclatasvir in Hepatitis C patients of genotype 1 have been presented
March 4

Used heroin needles suspected in rise of hepatitis C cases
March 4

AbbVie Hepatitis C Combo Cures Almost All Patients in Late Trial
March 3

HCV Prevalence Down Slightly
March 3

PEARL-III Study Results in Patients with Chronic Hepatitis C Presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI)
March 3

Racial Disparities in the Proportion of Current, Unresolved Hepatitis C Virus Infections in the United States, 2003-2010
March 3

There's a Life-Saving Hepatitis C Drug. But You May Not Be Able To Afford It
March 3

Costly hepatitis drug Sovaldi rattles industry
March 1

HCV Advocate Launches "The HCV Advocate Daily"
Feb 28

Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting
Feb 27

HCV prevalence, cost burden continue to rise
Feb 26

CDC Foundation and Lilly to Address Unsafe Injection Practices in U.S. Healthcare Settings
Feb 26

FDA Hepatitis Update - Changes to the Victrelis (boceprevir) label February 25, 2014
Feb 25

China: Henan Villagers Seek Justice for Damage Done by Hepatitis C Scandal
Feb 25

HCV increased risk for dying prematurely
Feb 25

UK: Organisation warns of risk to public from blood-borne diseases through increase in popularity of tattooing and body piercing
Feb 25

Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Feb 24

Social/behavioral intervention strategies may help drug users avoid injection-related HCV, HIV infections
Feb 24

New York State Hepatitis C Testing Law Frequently Asked Questions
Feb 24

South Berwick fined for lack of training in blood-borne pathogens
Feb 22

Son saves father's life by donating a portion of his liver
Feb 22

Elsmere tattoo shop shut; customers warned
Feb 21

Protein discovery may lead to hepatitis C vaccine
Feb 21

Groundbreaking method to test cure for hepatitis C: TT-034
Feb 21

Fighting Hepatitis C Among African Americans
Feb 21

'Plenty of good news' in health report, but work remains
Feb 21

Spain: Ten Alicante patients contract hepatitis through medical negligence
Feb 20

Australia: Hep C stigma causing pain and claiming lives amongst Aboriginal Australians
Feb 19

Fired worker sues Rhode Island Blood Center, alleging age and disability discrimination
Feb 18

Fired worker sues Rhode Island Blood Center, alleging age and disability discrimination
Feb 18

Sleep disturbance common in chronic HCV
Feb 18

Action Alert: Senate hearing scheduled for the new Maryland Hepatitis C testing bill – Feb 26, 2014
Feb 18

CANADA: Screening urged for Hepatitis C but drug costs are prohibitive
Feb 18

Needle exchange bill finds early support in Florida
Feb 18

Paul Farmer: Fighting hepatitis C: global lessons from AIDS
Feb 17

Update on infectious diseases — Implications for the dental office
Feb 17

Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance
Feb 17

Charity unveils refurbished HIV support centre to mark 25th birthday
Feb 17

Researchers Look to Reduce Hep C Infections with "Staying Safe Intervention" for Injecting Drug Users
Feb 14

Vitamin D levels failed to predict HCV treatment outcome
Feb 14

School nurse fined for forging signature on form
Feb 13

Fighting Hepatitis C Before It Gets To You (or Surprises You)
Feb 13

Canada: New online course helps people manage hepatitis C
Feb 13

FDA Hepatitis Update - Label update for Victrelis (boceprevir)
Feb 12

Current HCV therapies may not benefit older patients
Feb 12

Action Alert: AHF: Gilead's $1,000 Hepatitis C Pill Target of SF, NYC Protests Feb.12th
Feb 12

Canada: Hepatitis C patient can't access costly new drugs without private insurance
Feb 11

Triple therapy resulted in reduced fibrosis among patients with post-transplant recurrent HCV
Feb 11

Fair Pricing Coalition Policy Guide Reveals ACA Barriers to HIV, Hep C Treatment
Feb 11

Adult vaccination rates low states CDC, especially among Hispanics
Feb 10

Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C
Feb 10

Cincinnati needle exchange program launches in RV
Feb 10

The Hep C Race Is Heating Up: AbbVie Vs. Gilead
Feb 10

Newly found tactics in offense-defense struggle with hepatitis C virus
Feb 10

Vancouver home to Canada's first crackpipe vending machines
Feb 8

Maker Of $1,000 Hepatitis C Pill Looks To Cut Its Cost Overseas
Feb 7

Georgia Launches Programme to Curb Hepatitis
Feb 7

Patient Advocate Foundation Announces Co-Pay Relief (CPR) Support for Patients Living with Hepatitis C
Feb 5

Utah doctor helps craft attack plan for hepatitis C
Feb 4

UMass Memorial announces changes after Hepatitis C case
Feb 3

ASG Addresses Concern of Hepatitis C in Charlottesville Community
Feb 3

Gilead, local generic players in talks to bring hepatitis C drug into India
Feb 2

Ohio lawmakers might enable more clean needle exchanges
Feb 2

HepCBC Launches HCV Manifesto
Feb 1

FDA and Health Canada: Working Together for an Efficient Pathway for Drug Applications
Jan 31

Abbvie Strong Hep C Drug Data and the Looming Battle With Gilead Sciences
Jan 31

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Announces 2014 Development Road Map
Jan 31

AbbVie Completes Largest Phase III Program of an All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1
Jan 31

AHF to Ask States to Block Gilead's $1,000 per Pill Hepatitis Drug From Medicaid Formularies
Jan 29

Canada opposes harm reduction policies for drug users
Jan 29

Online Expert Advice for Clinicians Treating Hepatitis C Now Available at HCVguidelines.org
Jan 29

Activists moving against city to distribute free crack pipes to addicts
Jan 29

Scotland: Patient contracted hepatitis C during stay at Monklands Hospital
Jan 28

HOPE outreach van takes testing,information into the community
Jan 27

At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt
Jan 27

Mia Jones' bill would require doctors to offer Hepatitis C tests to Baby Boomers
Jan 22

NH House passes drug testing bill inspired by hepatitis C outbreak
Jan 22

100 Seattle Children's patients at risk from colonoscopy equipment
Jan 22

Bristol-Myers Squibb Hepatitis C Therapy Opens Up Combination Options
Jan 22

FDA Hepatitis Update - Victrelis (boceprevir) label changes update contraindications and drug interactions
Jan 22

Brantford General Hospital says human error may have led to Hep C contamination
Jan 21

France to deport Georgian citizens undergoing free treatment
Jan 21

Former TOTO Singer FERGIE FREDERIKSEN Dead At 62
Jan 20

The deadly toll of drug-approval drag
Jan 20

European Commission Grants Marketing Authorization for Gilead's Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Jan 20

Researchers closer to Hep C pill cure
Jan 16

New Treatments, New Complications for Those with Hepatitis C
Jan 16

First regional study on hepatitis C and HIV co-infection launched in Asia
Jan 16

Australia: Patients of dentist informed of possible exposure to HIV, hepatitis
Jan 16

UNMC part of international hepatitis C registry to improve treatment
Jan 14

Bristol-Myers Ties Hepatitis C Success to Gilead's Pill
Jan 14

Prevalence of Hepatitis C Infection Found to Vary Widely Among Hispanics
Jan 13

How much should we pay for medicines?
Jan 13

Canada: Abbotsford looks at repealing anti-harm-reduction bylaw
Jan 13

Interim results (SVR4) from a phase II all-oral combination study of Simeprevir and Samatasvir (IDX719) for the treatment of hepatitis C
Jan 13

Possible Hep B, Hep C, and HIV Outbreak at Northern Nevada Reservation
Jan 13

Hepatitis-C Outbreak: 787 People Fall Ill In South Kashmir
Jan 10

Widespread access to new HCV antivirals feasible within 15 years
Jan 10

License hearing for Tulsa dentist postponed
Jan 9

Vertex Announces Sustained Viral Response Rate (SVR4) Data from All-Oral Study of VX-135 in Combination with Daclatasvir in Hepatitis C
Jan 9

Novel Potential Approach to Prevent Infection in Patients with Liver Failure
Jan 9

Nurse exposed 24 inmates to 'blood-borne pathogen' at Buckeye prison
Jan 8

Daclatasvir Marketing Authorization Application for Treatment of Chronic Hepatitis C Validated for Accelerated Regulatory Review by the European Medicines Agency
Jan 8

Officials grappled with whether to inform public about unsterilized forceps
Jan 5

Anti-TB drug hepatotoxicity increased in those with HCV
Jan 2

 

Top News 2013

CDC: Flu widespread in 10 states, H1N1 dominates again
Dec 30

ND Health Department says it cannot identify source of transmission in hepatitis C outbreak
Dec 27

Scotland: Probe after patient gets hepatitis C in hospital
Dec 27

The Most Important New Drug Of 2013
Dec 26

Coffee, chocolate linked to improved liver health in HIV/HCV patients
Dec 26

New Hope for People with Liver Disease
Dec 26

Nigeria: Survey - 40 Million Nigerians Have Hepatitis Virus
Dec 24

Egyptians hold their breath as new Hepatitis C drugs promise cure
Dec 24

Hepatitis C Virus Proven to Remain Infectious for Up to Six Weeks on Surfaces
Dec 21

Protein links liver cancer with obesity, alcoholism, and hepatitis
Dec 20

Hepatitis C Transmission Confirmed in a Dental Setting
Dec 20

"Health Care Reform and Hepatitis C: A Convergence of Risk and Opportunity," a New Report from Milliman
Dec 20

Action Alert: Lift the federal ban on syringe exchange funding
Dec 19

Viral Hepatitis Testing Legislation Introduced in Congress
Dec 19

Hepatitis C Drug War Heats Up
Dec 18

Stellar hepatitis C data puts Gilead farther ahead of pack
Dec 18

Kansas City Doctor Behind New Breakthrough Hepatitis C Drug
Dec 18

Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients
Dec 18

New treatment for hepatitis C will change lives: Edmonton doctor
Dec 18

Raising Hope for Those Living With Hepatitis C
Dec 17

Fight for cheap drugs shifts to new Hepatitis from AIDS
Dec 16

Phase III data show Boehringer Ingelheim's faldaprevir* is effective even in patients with common drug-resistant viral variant
Dec 16

New drugs close in on hepatitis C cure
Dec 16

FDA Taking Closer Look at 'Antibacterial' Soap
Dec 16

Bone Mineral Density Measurements, Bone Markers and Serum Vitamin D Concentrations in Men with Chronic Non-Cirrhotic Untreated Hepatitis C
Dec 16

Health Canada Issues Notice of Compliance for Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Dec 16

High Risk of Decompensation With Precirrhosis in HIV/HCV+ People
Dec 13

An all-oral phase IIa study combining Simeprevir, TMC647055 and JNJ56914845 in hepatitis C patients to be initiated
Dec 13

Hepatitis C patients with fibrosis have more complications after TJA
Dec 12

NZ: Needles causing Hep C upsurge
Dec 11

Hepatitis Drugs Improve Kidney, Heart Diseases in Diabetics
Dec 11

Express Scripts Plans Price War for Gilead Hepatitis C Drug
Dec 10

AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
Dec 10

A Better Treatment for Hepatitis C
Dec 10

Physician Views: FDA throws up surprise labelling for Gilead Sciences' hepatitis C treatment Sovaldi – will it boost first year uptake?
Dec 9

Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™, and Urges Rapid and Wide Dissemination of Support Program Details for Uninsured and Underinsured People Living with Hepatitis C
Dec 9

EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus
Dec 9

Quincy lawmaker pushes statewide tattoo, piercing policies
Dec 6

AHF: Gilead Outrage on Hep C Drug Price!
Dec 6

FDA Hepatitis Update - Approval of Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C
Dec 6

What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Dec 6

U.S. Food and Drug Administration Approves Gilead's Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Dec 6

How Europe's Compassion for Hepatitis C Patients Helps Bristol-Myers
Dec 5

Lucinda Porter at Everyday Health: Navigating Hepatitis C
Dec 5

FDA Expected To Approve New, Gentler Cure For Hepatitis C
Dec 5

Liver Transplant Survival Rates Lower in Black than White Pediatric Patients
Dec 5

MassBiologics receives orphan drug status from FDA for hepatitis C treatment
Dec 4

Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results
Dec 4

Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis
Dec 4

Program Integrates Mental Health Care With Medical Care
Dec 4

Fixed-dose combination of sofosbuvir-ledipasvir alone or with ribavirin has the potential to cure most patients with genotype-1 HCV, irrespective of treatment history or the presence of compensated cirrhosis
Dec 3

Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself
Dec 3

NH Hospital Worker Gets 39 Years in Prison for Infecting Patients in 4 States With Hepatitis C
Dec 2

Impact of Interferon Free Regimens on Clinical and Cost Outcomes for Chronic Hepatitis C Genotype 1 Patients
Dec 2

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir plus the NS5A Inhibitor Ledipasvir or the NS5B Non-nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection.
Dec 2

Idenix Pharmaceuticals Announces Initiation of Enrollment in a Phase II All-Oral Combination Study of Samatasvir (IDX719), Simeprevir, and TMC647055 for the Treatment of Hepatitis C Virus (HCV) Infection
Dec 2

Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Dec 2

Hepatitis B and Hepatitis C in Pregnancy FAQ
Nov 29

Most detailed picture ever of key part of hepatitis C
Nov 28

Wales: Number of women infected with hepatitis C by former healthcare worker rises to four
Nov 28

Boehringer Ingelheim's faldaprevir granted accelerated assessment from European Medicines Agency
Nov 27

Experts suspect drug use might be behind surge of hepatitis C cases in Park County
Nov 26

Viral Hepatitis Training Resources for Health Care Providers/Professionals
Nov 25

Clinic gives addicts 1000 needles a day
Nov 25

Treatment Advocates Challenge Patent for New Hepatitis C Drug
Nov 24

U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection
Nov 22

European CHMP Adopts Positive Opinion for Gilead Sciences' Sovaldi® for the Treatment of Chronic Hepatitis C Infection
Nov 22

Kings County Hospital Center In Brooklyn Told Wrong Patients They Had HIV, Whistle-Blower Says
Nov 22

Antidepressant prophylaxis failed to improve HCV treatment completion
Nov 22

Cases of Hepatitis C & heroin use rising
Nov 21

Progress towards a hepatitis C virus vaccine
Nov 21

Biotron Limited receives green light for Hepatitis C virus treatment dosing study
Nov 20

INJECTION DRUG USE A survey uncovers grim numbers in London, Canada
Nov 20

HCC-based transplants straining donor pool, speaker says
Nov 20

'SILENT EPIDEMIC' | Nearly ten percent of Filipinos infected with hepatitis
Nov 20

Most Canadians infected with hepatitis unaware of it
Nov 20

New Treatment for Hepatitis C Approved by Health Canada Priority Review Gives Physicians and Patients an Effective and Tolerable Treatment Choice
Nov 20

Enanta sees success in trial of interferon-free pills for hepatitis C
Nov 18

FDA Uses New Authorities To Get OxyElite Pro Off the Market
Nov 18

AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
Nov 18

Nanaimo, BC: Hepatitis C rates show steady decline
Nov 16

Viral Hepatitis Symposium to Address Increasing Burden of Treatable Disease in Hawaii
Nov 14

ND: 35 in Minot area test positive for hepatitis C
Nov 12

Efficacy and safety of peginterferon plus ribavirin for patients aged ≥ 65 years with chronic hepatitis C: A systematic review and meta-analysis
Nov 12

Boceprevir, telaprevir linked to anemia in HCV-infected seniors
Nov 12

Rising Deaths from Hepatitis C Spur City Action
Nov 12

Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results
Nov 12

Late relapse after SVR may not be new HCV infection
Nov 11

CNIO scientists decipher how the immune system induces liver damage during hepatitis
Nov 8

BMS to end broad-based discovery research in hepatits C
Nov 8

Counterfeit syringes with serum against hepatitis found in drugstores in Romania, police starts investigation
Nov 8

Hepatitis C Outbreak in Wyoming
Nov 7

MEPs campaign against 'silent' hepatitis
Nov 7

Experts Release Landmark Findings and Recommendations on Hepatitis C in African Americans
Nov 6

AGA Publishes Tool to Help GIs Manage HCV Patients
Nov 5

Random drug testing taken out of hepatitis C bill
Nov 5

Hope on the Horizon for People with Hepatitis C Genotype 3, by Alan Franciscus
Nov 4

Hepatitis C, a Silent Killer, Meets Its Match
Nov 4

BMS Submits First All-Oral, Interferon-Free and Ribavirin-Free Treatment Regimen for Regulatory Review in Japan for Patients with Chronic Hepatitis C Infection
Nov 4

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Nov 1

Canada: More must be done to change course of hepatitis C virus
Nov 1

The Flu and Hepatitis C: High Risk of Complications
Nov 1

Study: Fibroscan – Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable
Oct 31

Physicians not following CDC guides on HCV screening
Oct 31

Viral Hepatitis Prevention Coordinators Convene in DC
Oct 31

Gay Men Should Be Tested for Hepatitis C, with comments by Alan Franciscus
Oct 30

FDA Hepatitis Update - Changes to Incivek (telaprevir) product labeling
Oct 29

Is the genotype 3 of the hepatitis C virus the new villain? with comments by Alan Franciscus
Oct 29

Seronegative hepatitis C virus infection in patients with lymphoproliferative disorders, with comments by Alan Franciscus
Oct 29

Canada: Experts worry tsunami of liver disease looms in hepatitis C-infected boomers
Oct 29

Vertex to Reduce Workforce Due to Decreased Sales of Incivek: Will Focus on VX-135, with Comments by Alan Franciscus
Oct 29

Draft Guidance for Industry on Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment; Availability—with comments by Alan Franciscus
Oct 28

When tiredness is a sign of the liver disease you caught years and years ago
Oct 28

Finding used needles in Moncton's urban haystacks
Oct 28

Hepatitis C checks for baby boomers now required
Oct 28

Anemia, rash among adverse events seen in HCV patients taking DAA
Oct 28

Pregnant women with hepatitis C may pass heartier viral strain to newborns, study suggests
Oct 28

HCV and Telemedicine: A Review – by Alan Franciscus
Oct 28

Lou Reed dead at 71: New York City rock pioneer, The Velvet Underground musician died Sunday
Oct 27

Alcoholism is a complicating factor for women with hepatitis C
Oct 27

Final report of bad blood inquiry delayed to 2014
Oct 26

FDA panel backs Gilead hepatitis C drug sofosbuvir
Oct 25

High-Risk Organs From Deceased Donors Safe When Screened with Current Methods
Oct 25

FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
Oct 24

Biotron's drug enhances antiviral activity in HIV/HCV infected patients
Oct 24

Australia: Health groups backing plan for needle exchange
Oct 24

Former endoscopy clinic owner sentenced to life in prison in 2007 Vegas hepatitis C cases
Oct 24

Diabetes mellitus demonstrated as independent predictor of cirrhosis, hepatocellular carcinoma
Oct 24

Georgia: Government to cut the price of hepatitis C treatment
Oct 24

Interview with Lucinda Porter, RN, author of newly released Hepatitis C Treatment One Step at a Time and Free from Hepatitis C
Oct 23

Unmet Need in Hepatitis C Gets Boost from Innovative Partnership
Oct 23

Cuomo signs bill to promote Hepatitis C testing
Oct 23

Hepatitis C rates soar - Boomers should get tested
Oct 23

Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
Oct 22

FDA Reviews 2 Promising New Drugs For Hepatitis C
Oct 22

Health board nixes needle exchange startup in Colorado Springs
Oct 22

J&J-Medivir's Drug Works Against Hepatitis C
Oct 22

Faldaprevir plus peginterferon/ribavirin improved response in HCV patients
Oct 21

Help-4-Hep, a Free Nationwide Helpline, Addresses Increasing Concerns about National Incidence of Hepatitis C
Oct 21

Ohio House Passes Clean Needle Bill: Now It's Up to the Senate
Oct 21

Living With Hepatitis C: How To Tell Others
Oct 21

Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial
Oct 21

Cuomo should sign bill to offer screening for hepatitis C
Oct 20

Good news for people with hepatitis and advanced liver scarring: Prolactin may help in liver regeneration
Oct 20

New Genotype Identified—Genotype 7 and 67 Subtypes
Oct 19

Study determines SVR predictors in HIV/HCV coinfected patients
Oct 19

Health officials probe hepatitis C outbreak in ND
Oct 19

If You Have Hepatitis, You Don't Want to Get Bitten by These!
Oct 18

Direct-acting antivirals expected to 'revolutionize' HIV/HCV coinfection treatment
Oct 18

Hepatitis warning over tattoos and body piercing
Oct 18

Medivir announces data from two phase III studies with Simeprevir in hepatitis C subpopulations – HCV/HIV co-infected and genotype 4 infected patients
Oct 18

Multicountry Survey Results Highlighting Limited Knowledge of Viral Hepatitis and Liver Cancer Reinforces Need for Action
Oct 17

HCV Drug Pipeline: A New Era is Dawning in Hepatitis C Therapy
Oct 15

'Silent disease' hepatitis C remains major public health problem in Merseyside
Oct 15

NY Can Lead Nation in Protecting Baby Boomer Health with Hep C Action by Cuomo
Oct 14

Warning: Vibrio Bacteria in saltwater infect 31, kill 10 in Florida
Oct 11

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients
Oct 11

NYC launches initiative to control hepatitis C prevalence in the city
Oct 11

Wales: Hepatitis C alert - more than 2,400 blood tests taken by Gwent patients
Oct 11

Krokodil, The Flesh-Eating Street Drug That Rots Skin From Inside-Out, Expands To Illinois
Oct 11

Tattoos, drug use primary HCV risk factors in Mexican prison population
Oct 10

Acute Hepatitis and Liver Failure Following the Use of a Dietary Supplement Intended for Weight Loss or Muscle Building
Oct 10

Science unveils sinister side to tattoo craze
Oct 8

Sofosbuvir and SOC for HIV/HCV Coinfected Patients: Comments by Alan Franciscus
Oct 8

Boehringer Ingelheim (BI) announces interim Phase 2 data from a small interferon-free study of HCV genotype 1a patients treated with faldaprevir, deleobuvir and Presidio Pharmaceutical's PPI-668 with and without RBV for 12 weeks.
Oct 8

Janssen announces acquisition of GSK's GSK2336805—an HCV NS5a inhibitor for the treatment of HCV genotype 1 patients
Oct 8

Interim Analysis of an Interferon (IFN)- And Ribavirin (RBV)-Free Regimen of Daclatasvir (DCV), Asunaprevir (ASV), and BMS-791325 In Treatment-Naive, Hepatitis C Virus Genotype 1-Infected Patients
Oct 7

Some Notes on Mother-to-Child Transmission of Hepatitis C, by Alan Franciscus
Oct 7

Liver fibrosis linked to immune activation in HIV/HCV co-infected women
Oct 7

Several factors predicted interferon-based therapy response in HIV/HCV coinfection
Oct 7

Medivir: Simeprevir data from COSMOS study in Hepatitis C patients will be presented as late-breaking presentation at AASLD
Oct 7

Hepatitis C Treatment One Step at a Time: Inspiration and Practical Tips for Successful Treatment, by Lucinda K. Porter, RN; foreword by Diana Sylvestre MD
Oct 6

Hepatitis C education crucial to cut high infection rate in Middle East and North Africa
Oct 6

Testing High Risk Adults Complements Testing of the Baby Boomer Populations
Oct 6

About 75,000 People Could Die from Hepatitis C Every Year in the US
Oct 6

Sofosbuvir and SOC in Treatment-naïve HIV/HCV Coinfected Patients
Oct 5

HCV transmitted from organ donor with negative nucleic acid test
Oct 5

UK: New injection device delivers optimum treatment dose to hepatitis C patients
Oct 5

Natural Human IFN-β + Ribavirin Safe, Effective in Patients with Hepatitis C and Depression
Oct 4

Researchers create tool to calculate risk of ESRD after liver transplant
Oct 3

Hepatitis C Treatment in Ukraine: A Victory For Patients — Costs held to US $5000 for 1 year of treatment
Oct 2

Needle-exchange bill advances in Ohio Legislature
Oct 2

Plastic surgery clinic warned of risk of infection
Oct 2

Fibrosis progression common in HIV/HCV coinfection; linked to serum transaminase
Oct 2

Adding Danoprevir Boosts Response to Interferon-based Therapy for Hepatitis C
Oct 2

Bristol-Myers Squibb to Present Range of New Hepatitis C Data at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Oct 1

Idenix Pharmaceuticals Announces Nucleotide Prodrug Program Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Oct 1

Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Oct 1

Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
Oct 1

AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Oct 1

Data from Merck's Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting
Oct 1

A Note about Sofosbuvir
Oct 1

Report by scientists of a new hepatitis virus earlier this year was a false alarm
Oct 1

When tattoos go wrong
Sept 30

Telaprevir-based triple therapy outweighed risks for adverse events
Sept 30

Canada: Liver doctors seek hepatitis C screens for baby boomers
Sept 30

Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk
Sept 30

Response to Hepatitis C treatment: no benefits and possible harm, By Ronald Koretz, M.D., by Lucinda K. Porter, RN
Sept 29

Herbs and Hepatitis C: An HCSP Factsheet, by Lucinda K. Porter, RN - Updated
Sept 27

DOH investigating possible diet supplement tie to recent Hepatitis, liver failure cases
Sept 27

Simeprevir has been approved in Japan for the treatment of genotype 1 chronic hepatitis C infection
Sept 27

Danoprevir improved SVR rate from peginterferon/ribavirin therapy in HCV patients
Sept 27

Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people
Sept 27

HIV and hepatitis a fear on Olympia playgrounds
Sept 26

The View from the Frontlines: The status of HCV-monoinfected persons in Canada, presented at the CATIE 2013 conference, by Cheryl Reitz
Sept 25

Roche/Genentech HCV Survey in Miami, Washington DC & Philadelphia Reports Data on Stigma, Lack of Awareness, Not Being Tested or Spoken to a Doctor About HCV
Sept 25

'Tainted' tells story of Canada's blood scandal through affected family's eyes
Sept 25

A Guide to the Affordable Care Act (ACA)
Sept 25

CDC: Hepatitis A Outbreak Now at 162 Cases in 10 States
Sept 25

UK urges gyms to provide needles for steroid users
Sept 25

N.H. studies lessons from hepatitis C probe
Sept 25

Resource utilization for HCV unchanged, Medicare patient responsibility increased over time
Sept 24

Andrew's Story: A Tale of Courage Beyond Imagining
Sept 24

GSK receives marketing authorisation from the European Commission for additional Revolade™ (eltrombopag) indication as the first approved treatment for chronic hepatitis C-associated thrombocytopenia
Sept 24

OSAP Offers Hepatitis C Prevention Informational Toolkit
Sept 21

Update on Renewal of Viral Hepatitis Action Plan
Sept 21

Canada: Specialists warn of a looming hepatitis C crisis
Sept 21

Worse Response to PegIFN/RBV for HCV After Transplant in HIV/HCV+ vs HCV+
Sept 20

Patient Profile: Living With Childhood Hepatitis C
Sept 20

Tainted blood survivor considers himself lucky
Sept 20

Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma
Sept 19

Interferon response reduces liver disease and death in HIV/HCV co-infected people
Sept 19

3 Companies Racing to Transform Hepatitis-C Treatment
Sept 18

Raw Oyster–associated Vibrio vulnificus Illnesses and Deaths
Sept 18

Investigation of Hepatitis E Outbreak Among Refugees — Upper Nile, South Sudan, 2012-2013
Sept 18

Hepatitis E Virus Found in 10% of Sausages Tested in Britain
Sept 18

Proof that Hepatitis C Was Spread at Dental Clinic
Sept 18

Single-Port Liver Resection Safe, Feasible in Selected Patients
Sept 17

Drug therapy offers new hope to hepatitis C patients
Sept 15

All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)
Sept 15

When Is Racial Profiling OK? In the Doctor's Office
Sept 15

Nagaland: Signature Campaign on Hep-C begins
Sept 14

Hepatitis E virus infection associated with HIV and damage to gut mucosa, Zambian study shows
Sept 13

HIV and hepatitis risk for steroid users
Sept 13

Targeted HCV screening effectively identified infected former drug users
Sept 13

Public Often Clueless About Medicare
Sept 12

Hepatitis E Increase Points to Foodborne Source
Sept 12

HCV, waist circumference linked to greater liver stiffness
Sept 12

Women Have Higher Rate of Spontaneous Clearance of Hepatitis C Virus
Sept 12

Hepatitis fear at Welsh hospitals as patients infected
Sept 11

Treated patients with HCV incur lower health care costs
Sept 11

Alliance Ukraine Brokers Deal for Significant Reduction in Cost of HCV Treatment
Sept 11

Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
Sept 10

Indonesia's Hidden Hepatitis C Time Bomb
Sept 9

Hepatitis Continues To Plague Eastern Kentucky
Sept 9

Hepatitis C services in the UK: an interview with Louise Campbell, senior liver nurse at Imperial College Healthcare NHS Trust
Sept 9

Acute HCV exacerbation yields poor outcomes; does not inhibit SVR
Sept 9

Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study.
Sept 9

National Coverage Determination (NCD) process for adding hepatitis C testing to Medicare
Sept 6

Dietary, activity improvements benefited overweight, obese HCV patients
Sept 6

Biomarker Discovery for Early Detection of Hepatocellular Carcinoma (HCC) in Hepatitis C (HCV) Infected Patients
Sept 6

Telaprevir triple therapy shows activity against HCV genotype 4
Sept 5

Second victim dies from hepatitis C outbreak at Dr. Desai's clinic
Sept 5

From the Editor: Hospital Readmission Rate 31.9% for Patients with Sickle Cell Anemia
Sept 5

Rapid detection and identification of hepatitis C virus (HCV) sequences using mismatch-tolerant hybridization probes: A general method for analysis of sequence variation
Sept 5

POST-RELEASE: Protest action in front of the Russian Ministry of Health "TO TREAT HEPATITIS C? CHEAPER TO BURY…"
Sept 4

RVR, baseline characteristics identify patients who will benefit from dual HCV therapy
Sept 4

Maternal transmission cause of HCV in children
Sept 4

Study examines ways to restore immunity to chronic hepatitis C infection
Sept 3

Smart syringe turns red to tell you it's been used
Sept 3

Decompensated cirrhosis increases risk of liver cancer for people with HIV and viral hepatitis co-infection
Sept 3

Curing Hepatitis C
Sept 1

Study helps characterize HCV exacerbation course, outcomes
Sept 1

Obit: Remembering Ken Thomson
Sept 1

Gilead Sues Merck Saying New Drug Won't Infringe Patents
Aug 30

Liver Cancer Due to Chronic Inflammation: Tumor Growth Follows Programmed Cell Death (Apoptosis)
Aug 30

FDA, academia and industry team up to end hepatitis C
Aug 29

N.B. hospital used unsterilized biopsy forceps for 14 years
Aug 29

New protease inhibitors showing promise for HIV/HCV coinfection
Aug 29

Frequent coffee, chocolate consumption reduced liver enzymes in HIV/HCV coinfected patients
Aug 29

Canada: Hep C rise baffles experts in Nova Scotia
Aug 28

Medivir announces interim results from Cohort 2 of the COSMOS study evaluating Simeprevir and Sofosbuvir in HCV patients with METAVIR scores F3-F4
Aug 28

B.C. HEPATITIS C LIVER TRANSPLANT PATIENTS FROM OUTSIDE VANCOUVER FACE ADDITIONAL HURDLES
Aug 27

Investigational Oral Regimen for Hepatitis C Shows Promise in NIH Trial
Aug 27

Vertex's VX-135 partial hold signals heightened FDA scrutiny toward HCV drugs
Aug 27

Hepatitis C response bill altered
Aug 27

Santaris Pharma A/S Completes Enrollment in Phase 2 Clinical Trial of Miravirsen
Aug 27

Duluth leaders dislike site of needle swap program
Aug 26

Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California
Aug 24

To curb disease, program to give free drug needles
Aug 24

"Lemons to Lemonaid": John's Story
Aug 23

Canada: URGENT REQUEST FOR YOUR INPUT into a new HCV drug, SIMEPREVIR
Aug 23

Judge dismisses claim over company pot policy
Aug 23

Hepatitis A scare at Upper West Side market after food handler falls ill
Aug 23

Faldaprevir and deleobuvir for HCV genotype 1 infection
Aug 22

High proportion of Canadian patients with HIV-HCV co-infection and liver cirrhosis are not having ultrasounds to check for liver cancer
Aug 22

Mental, physical health, fatigue worsened by antiviral therapy, anemia in HCV
Aug 22

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-Naïve genotype 1 hepatitis C: The randomized PILLAR study
Aug 21

Expect miracles: New drug for hepatitis C may put treatment in the hands of primary care
Aug 21

NZ: Newly Funded Hepatitis C Treatment Will Help Curb Epidemic
Aug 21

Third International Symposium on Hepatitis Care in Substance Users, Munich, Germany
Aug 21

Evaluation of liver disease progression in the German HCV (1b)-contaminated anti-D cohort at 35 years after infection
Aug 21

Hepascore predictive of mortality, morbidity in chronic HCV
Aug 20

Surveillance for Hepatitis C – United States, 2000 - 2011
Aug 20

Cleared HCV infection associated with increased risk of kidney disease in people with HIV
Aug 20

Presence of HCV symptoms reason for testing in almost half of infected patients
Aug 19

The Other Forgotten Hepatitis B Minority—African-Americans
Aug 19

Raider Nation gives 'Raider Ron' Rickard hope for liver transplant
Aug 19

Coffee and Tea May Contribute to a Healthy Liver
Aug 17

Breaking the Silence: Voices of Chronic Hepatitis C - Feature Documentary
Aug 17

Locations and Reasons for Initial Testing for Hepatitis C Infection — Chronic Hepatitis Cohort Study, United States, 2006–2010
Aug 16

Deadly liver cancer on the rise, but half of cases preventable: Cancer Society
Aug 16

Emory seeks patent on Hepatitis C treatment
Aug 16

Absolute lymphocyte count predictive of HCV recurrence post-liver transplant
Aug 16

Advanced fibrosis raised risk for decompensation in HIV/HCV coinfection
Aug 15

Medivir makes strategic decision to focus proprietary hepatitis C R&D efforts exclusively on nucleotide-based polymerase inhibitors
Aug 15

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
Aug 14

HIV Information Booklet by Liz Highleyman, Updated
Aug 14

New Hampshire hospital worker pleads guilty in hepatitis case
Aug 13

North Dakota: Department of Health Investigates Hepatitis C Cases
Aug 12

Hepatitis almost as lethal as HIV despite lack of awareness
Aug 12

Former Smithfield officer finally can declare victory
Aug 11

Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality
Aug 9

Even Liver Specialists Fail to Immunize Patients Against Viral Hepatitis
Aug 9

HCV viremic, aviremic individuals at risk for CKD
Aug 9

IL28B, HCV genotypes, sex linked to spontaneous acute HCV clearance
Aug 9

Doing the maths to cut Hepatitis C in injecting drug users
Aug 8

Heroin Makes a Comeback
Aug 8

Baby Boomers at Risk for Hepatitis in the African-American Community
Aug 8

Hepatitis C: Facing a threat to baby boomer health head-on
Aug 8

Community study finds no evidence of widespread HCV epidemic among HIV-negative gay men in London
Aug 7

HCSP Launches New "HIV Basics" Fact Sheet Series
Aug 6

HCV & Diabetes: What You Need to Know
Aug 6

Australia: Researchers call for increased Hep C treatment for drug users
Aug 6

Exercise May Reduce Heart Disease Risk in Liver Transplant Recipients
Aug 6

Biotest AG: First patient treated with CivacirTM after Hepatitis C induced liver transplantation in Biotest's Phase III clinical trial
Aug 5

Discrepancy found between HCV surveillance systems
Aug 5

Canada: It's important baby boomers be tested for Hepatitis C
Aug 4

Mount Sinai researchers develop first successful laboratory model for studying hepatitis C
Aug 3

Hepatitis rates must be measured
Aug 2

Losing a Tattoo, Gaining a Tumor
Aug 2

Clinical and epidemiological features of hepatitis C virus infection in South Korea: A prospective, multicenter cohort study.
Aug 2

Curing Hepatitis C
Aug 1

FDA Warns of Rare Acetaminophen Risk
Aug 1

Engineered mice act as hepatitis C model
July 31

"C" This Is What It Is Concert: August 31, 2013
July 31

White House Hosts U.S. Observance of World Hepatitis Day
July 31

Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
July 31

To End Hepatitis C, Patients Must Come Before Profits
July 30

A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C
July 30

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago
July 30

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim
July 30

Leading Liver and ID Experts to Develop Hepatitis C Practice Recommendations
July 29

Mislabeled Aspirin Increases Risk of Liver Damage
July 29

GSK gets positive CHMP opinion for Revoladein for thrombocytopenia associated with chronic hepatitis C infection
July 29

Obamacare may give OraSure product a boost
July 29

Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems
July 29

Investigators identify genetic profile associated with better treatment outcomes in people with HIV/HCV co-infection
July 29

Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor
July 28

Editorial: World Hepatitis Day 2013
July 27

NGO sounds alarm on rising hepatitis deaths in Asia
July 26

P.E.I. Hepatitis C increase linked to IV drug use
July 26

Miriam researcher helps develop global hepatitis C recommendations for injection-drug users
July 26

WHO: over 350,000 people die each year from hepatitis C-related diseases
July 26

Temperature increase after interferon-based HCV treatment linked to virological response
July 26

Vertex Provides Update on Ongoing All-Oral Studies of VX-135 in Hepatitis C
July 25

U.S. FDA puts hold on Vertex hepatitis study; shares fall
July 25

Hepatitis C on sharp rise in China
July 25

Hepatitis C on rise due to heroin use
July 25

Number of patients diagnosed with HCV in England increased by a third between 2010 and 2012
July 25

Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C
July 25

NY'ers Block Traffic & Occupy World Health Organization To Protest Leadership Failure
July 25

Get Involved on World Hepatitis Day: Get Involved in Clinical Trials
July 25

U.S. drugmakers cheer 'speed lane' for breakthrough therapies
July 24

Inaugural African American Hepatitis C Action Day Promotes Education, Testing, and Treatment to Reduce High Rates of HCV in Black Communities
July 24

WHO urges governments to act on hepatitis threat
July 24

Hepatitis is a silent epidemic that kills two people per minute throughout the world
July 24

20pc of prisoners have hepatitis B and C: latest health report
July 24

Colossal human tragedy in South Kashmir
July 24

Hepatitis C rages in Georgia
July 24

Report explores the inequity in treatment access for people living with HIV and Hepatitis C co-infection in Canada
July 24

World Hepatitis Day: July 28
July 23

Hep B or C Coinfection Spells Worse Response to HIV Meds
July 23

Post-Cure Hep C Reinfection Is Common Among Prisoners
July 23

Research: Some African American liver recipients fare better with organ from black donor
July 22

Australia: Thousands of Hepatitis sufferers not seeking treatment
July 22

Marijuana Does Not Promote Liver Disease Progression in HIV/HCV Coinfected People
July 19

HCV decline associated with needle and syringe programs
July 19

No link between neutropenia, infection during interferon-based therapy in HIV/HCV coinfection
July 19

Action Alert: Urge Your Members of Congress to Attend the "We Can Eliminate Viral Hepatitis" Briefing on July 25th
July 19

NICE OKs hep C treatment for children
July 18

FDA Reminds Consumers to Always Use Acetaminophen Safely
July 18

Telaprevir/PEG/RBV in HIV-1/HCV Coinfected People
July 18

U.S. sees lower-than-expected Obamacare insurance costs
July 18

A Note on the Affordable Care Act: 'Obamacare' to slash individual New Yorkers' health insurance rates by 50 percent
July 17

DOH Encourages Awareness of Potential Bacteria in Gulf Waters
July 16

Virginia Tech professor to study spread of hepatitis E between people and animals
July 16

Roadshow urges Cambridgeshire public to get tested for virus
July 16

Letter: Boomers should be tested for hepatitis C
July 16

Occult, overt HBV coinfection predictive of outcomes from HCV-associated HCC
July 16

The Burden of Liver Disease Increases
July 15

HCV disease burden greatest among baby boomer veterans
July 15

A brighter future in the fight against hepatitis
July 13

Abbotsford, B.C., defends bylaw restricting harm-reduction after drug users sue
July 13

Danoprevir enhances sustained HCV response rates
July 13

Contesting a medical bill can be a tedious process
July 12

Renal impairment common with telaprevir, boceprevir therapy for HCV
July 12

Quest Diagnostics Partners with CDC to Improve Hepatitis C Public Health Research to Promote Early Detection and Medical Intervention
July 11

Toronto's board of health becomes first governing body in Ontario to endorse drug injection sites
July 11

Marijuana not associated with liver disease progression in HIV/HCV coinfection
July 10

Reflex RNA testing should follow a positive HCV antibody test
July 10

Around 18,000 Scots infected with Hepatitis C without knowning
July 9

The threat of a new epidemic
July 9

Poorer Health for Acetaminophen Overdose Survivors than Other Liver Failure Patients
July 9

Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people
July 8

Gov. Cuomo should act to expand access to hepatitis C testing: Commentary
July 6

Wollongong has one of the highest rates of hepatitis C in Australia according to a nationwide survey
July 5

High SVR rates with DAA regimen among chronic HCV patients
July 5

Scientists create tiny human liver cells from stem cells
July 3

State Health Officials Encourage Use of Free Hepatitis C Testing Program
July 3

Preliminary results suggest safety, efficacy of tremelimumab as HCC, HCV therapy
July 2

Hepatitis C reinfection occurs frequently among gay men living with HIV in London
July 2

Jury convicts former doctor in Vegas hep C case
July 2

AbbVie interferon-free hepatitis C combo works well with reduced ribavirin dose
July 2

Myths about Weight Loss
July 1

HEALTHWISE: Technically Speaking: Apps and Hepatitis C
July 1

Snapshots
July 1

EASL 2013: DAAs Look Good, but Challenges Remain—Part 2
July 1

FDA Puts Achillion Hepatitis C Drug on Clinical Hold
July 1

Hepatitis C News Team Launch New Online Hep C TV Channel
July 1

Lawmakers to NY Docs: Screen All Baby Boomers for Deadly Liver Disease
July 1

Hepatitis Threat Forces Another Frozen Fruit Recall
June 29

Jury to begin deliberating in hepatitis C case against ex-Vegas clinic owner, employee
June 28

77 hepatitis C cases reported in Okla. infection scandal
June 28

HCV triple therapy post-liver transplant yields moderate response, significant adverse events
June 27

Dietary Cholesterol Promotes Progression in Hepatitis C
June 26

Flu Shot Effective Regardless of Circulating Flu Strain, Research Finds
June 26

Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients
June 25

Hepatitis C Test for Baby Boomers Urged by Health Panel
June 24

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement
June 24

UAB Hospital Emergency Department to screen patients for hepatitis C
June 21

NH releases report on hepatitis C outbreak
June 21

State Legislature passes bill requiring doctors to offer hepatitis C tests to baby boomers
June 20

Idenix sees delay in human trials for hep C drug as FDA seeks more data
June 20

FDA Approves Abbott Test for Identifying Hepatitis C Genotypes
June 20

SVR more dependent on adherence to treatment duration than dosing interval
June 20

HHS Releases New Guideline to Reduce Disease Transmission Through Organ Transplantation
June 20

SVR after triple therapy maintained long-term durability in HCV patients
June 20

Folsom Man Files Suit after Contracting Hepatitis from Berries
June 19

A Public Health And Healthcare Spending Time Bomb: Hepatitis C
June 19

Investigational Device Prolongs Survival Of Livers for Transplantation
June 18

A killer with a silent step
June 17

Hep C test bill clears Assembly
June 17

Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection
June 17

Clarifying hepatitis C data
June 17

Patients with HCV, occult HBV at greater risk for mortality, HCC, cirrhosis
June 17

Hepatology 2013: 4th Edition Available
June 17

The FDA Makes Hepatitis C a Priority
June 16

HepFest provides Hepatitis C awareness
June 16

Free HIV, Hepatitis Testing for Patients of Former Tulsa Oral Surgeon to End June 28
June 15

AbbVie Says It Can Beat Gilead in Race for New Hepatitis C Drugs
June 14

Future HCV therapies will improve SVR rates, treatment durations, tolerability
June 14

No impact on acute rejection from interferon/ribavirin HCV therapy among renal transplant recipients
June 14

Inside HCV: An Interview with Janssen
June 14

Simeprevir keeps HCV at bay in treatment-naive and experienced patients
June 13

UAlbany Research Aims to Open Doors to Therapies for Hepatitis C
June 13

Hepatitis C Virus: Is the end in sight?
June 13

Medina County Health Department offers free Hepatitis C screening June 17
June 12

Hepatitis C Testing Legislation Advances
June 12

Rates of Hepatitis C double in P.E.I.
June 12

How Did Hepatitis Get into Organic Berries?
June 12

Interferon-based therapy benefited HCV/HIV coinfected patients despite viral relapse
June 12

Most of us are slackers when it comes to hand washing
June 12

Italy leads Europe in hepatitis C cases
June 11

Hep C poorly managed in haemophiliacs
June 11

Hep C knowledge gap endangering children
June 11

NBLCA Supports Proposed New York State Legislation That Would Expand Testing for Hepatitis C Virus in Baby Boomers—Rally June 11, 2013
June 10

Hepatitis C 101: Protecting High-Risk Baby Boomers and Vulnerable Communities From the Silent Epidemic
June 10

New Loyola study on hepatitis C virus entry factor
June 10

Partial Livers from Deceased Donors Saving the Lives of Infants
June 10

Hepatitis C Infection Among Young Injection Drug Users: Addressing an Emerging Trend
June 8

Boehringer Ingelheim's investigational faldaprevir+ achieved viral cure in 88% of treatment-naïve hepatitis C patients in Asia
June 7

FDA grants priority review status to Gilead's hepatitis C drug
June 7

Hepatitis B and C infect one in fifty adults in European Region
June 7

Morbidity Associated with Telaprevir-based HCV Treatment Much Greater in Real-World Practice
June 7

160,000 Singaporeans suffer from Hepatitis B, Chronic Hepatitis B
June 7

Angels' Share actor Paul Brannigan in support of hepatitis C film
June 6

DHHS Announces New Case of Hepatitis C Associated with a Previous Exeter Hospital Outbreak Case
June 6

Primary efficacy and safety data from four phase III Japanese studies of Simeprevir presented at The Japan Society of Hepatology
June 6

Harper government to throw up roadblocks for supervised injection sites
June 6

Input sought on renewal of U.S. Viral Hepatitis Action Plan (comments need to be made by 5:00 p.m. EST on July 5, 2013)
June 6

U.S. government report "Hepatitis C Virus Infection in Young Persons Who Inject Drugs"
June 6

Pa. health officials: dentist's patients at risk
June 5

Ohio General Assembly should move syringe bill along: editorial
June 5

High rate of Hepatitis C lead to calls for rural needle exchanges
June 5

Boceprevir benefits null, partial responders to prior HCV therapy with peginterferon/ribavirin
June 4

Blood Tests OK for Fibrosis Dx in Hep C
June 3

Drugs Go From Hit to Dud in $15 Billion Hepatitis Race
June 3

Quebec hospital wants 1,000 patients to come in for HIV, hepatitis tests
June 3

30 Hepatitis A Illnesses Linked to Organic Berries Sold at Costco
May 31

New Agent Inhibits HCV Replication in Mouse Models: No Resistance Seen
May 31

INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)
May 31

Social, welfare and structural interventions needed to improve HCV treatment access for people who inject drugs
May 30

Idenix Pharmaceuticals Announces Initiation of Phase II All-Oral Combination Study of Samatasvir (IDX719) and Simeprevir (TMC435) for the Treatment of Hepatitis C Virus (HCV) Infection
May 30

Achillion Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV
May 30

UPDATE 1-GSK bets on chimp virus with $321 mln vaccines buy
May 30

War on drugs 'driving hepatitis C pandemic'
May 29

Liver cancer rates on the rise in Canada, new stats reveal
May 29

Govt urged to consider opening injection centres for addicts
May 28

Unsafe Injection Practices Remain All-Too-Common
May 28

Hospital: Some hepatitis C patients cured
May 26

Risks small between HCV patients' use of DAAs, neuropsychiatric events
May 24

HCV Prevalence Higher Among Asian-Americans
May 23

May 23, 2013, is Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives

Andrew Muir, MD, analyzes recent hepatitis C clinical trial results
May 22

Hepatitis C: A 21st Century Success Story (Op-Ed)
May 22

Catskill Regional Medical Center alerting patients
May 22

Volunteer supports those with Hepatitis C
May 22

European Medicines Agency Validates Gilead's Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 22

Interferon-free, treat-all approach cost effective, beneficial for chronic HCV
May 21

New facility unveiled for homeless with Hepatitis C
May 21

SVR associated with lower risk for diabetes in HCV
May 21

Hepatitis C and Dietary Supplements: What the Science Says
May 21

Health department hosts free Hepatitis Health Fair
May 21

Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
May 21

Action Alert: Urge Your Members of Congress to Participate in Historic Viral Hepatitis Testing Event
May 20

Health sites too complex, full of cliches: study
May 20

HCV patients with late viral breakthrough have similar characteristics
May 19

Hep C Infections Largely Undiscovered
May 16

Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
May 16

Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
May 16

Free Hepatitis Screening Offered on Monday, May 20 Hawai`i
May 15

Charlottesville Nonprofit Offering Free Hepatitis C Testing
May 15

Annual Ken Zebrowski Memorial Walk Supports Hepatitis C Research
May 15

Hepatitis E virus infection can cause rapid liver cirrhosis in people with HIV who have low CD4 cell counts
May 15

Health board takes no action on Tulsa dentist
May 15

Centre will assist Hepatitis C patients
May 15

Screening Events Promote Hepatitis Testing and Prevention during National Hepatitis Awareness Month
May 15

OraSure Technologies, Walgreens and Chronic Liver Disease Foundation to Launch Rapid Hepatitis C Testing Initiative in Support of National Hepatitis Testing Day
May 14

New HCV combinations could have a big role in prevention, but only if treatment rates increase
May 14

Hepatitis Activists Issue New PSA and Call Attention to Open Enrollment for Affordable Care Act
May 14

US FDA grants orphan drug status to Jennerex's Pexa-Vec for treatment liver cancer
May 13

Lourdes Doctors Urge Testing During Hepatitis Awareness Month
May 13

Hepatitis C education important
May 13

U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
May 13

Free hepatitis testing for at-risk individuals—May 17, at the Health District, 3020 Rucker Ave, Suite 106, Everett.
May 12

Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
May 12

Hepatitis C RNA Testing Recommended for All Positive HCV Antibody Tests
May 12

HCC risk persists 8 years after HCV eradication
May 10

20 veterans test positive for hepatitis
May 8

CDC: 75 percent in U.S. with hepatitis C don't know they are infected
May 8

Many in U.S. don't get proper testing for hepatitis C: CDC
May 7

New Antiviral Treatment Could Significantly Reduce Global Burden of Hepatitis C
May 6

AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
May 6

Gairdner Foundation honours two of three prizewinners for hepatitis C research
May 2

Gilead combo hepatitis C pill effective in small trial
May 2

Updates from Amsterdam: HCV Emerging Therapies - Understanding the Science Behind the Clinical Data
May 2

Gastroenterology in the 21st Century: Optimizing Patient Outcomes
May 2

Targeted drugs to tackle hepatitis C
May 1

Hep C one of fastest-growing infectious diseases
May 1

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
May 1

HCV screening of prison inmate drug users: an interview with Dr. Arthur Kim, Massachusetts General Hospital and Harvard Medical School
May 1

Sharecare Names Top 10 Social HealthMakers in Hepatitis C
May 1

Hep C quad regimens quashed, but some components go forward
April 29

Successful Hep-C Combo May Elude Patients as Gilead Goes Solo
April 29

Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care
April 29

BioLineRx Enrolls First Patient in Phase I/II Clinical Trial for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
April 29

Attention Baby Boomers: Get Screened for Hepatitis C
April 27

Hepatitis C: Closing in on its viral origins
April 27

Anemia Top Side Effect of HCV Antivirals
April 27

Hemophilia Ontario wants paid plasma clinics delayed
April 26

Research finds targeted screening for hepatitis C is cost-effective
April 24

Hepatitis C found among Irish people who travelled overseas for dental treatment
April 24

Hepatitis c-like viruses identified in bats and rodents
April 24

Hepatitis C drug nears approval
April 23

Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C
April 22

Dozens of Okla. dentist's patients positive for hepatitis
April 18

FDA Approves FibroScan for Non-invasive Liver Diagnosis
April 17

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT‐034 in Patients with Hepatitis C Infections
April 16

Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV
April 16

Roche to commercialize Hepatitis C drug in China with Ascletis
April 15

CROI 2013: Telaprevir Triple Therapy Improves HCV Response for Black Null Responders
April 12

Study reveals Rx target for HPV, Hep C and related cancers
April 11

Jury awards record $524M in Hep C case; lawyer calls verdict a wake-up call to health insurers
April 11

Daclatasvir/asunaprevir effective in difficult-to-treat HCV populations
April 11

Merck to Present New Data on VICTRELIS® (boceprevir) and Investigational Compounds MK-5172 and Vaniprevir for Chronic Hepatitis C Virus at The International Liver CongressTM / 2013 EASL Annual Meeting
April 10

ACTION ALERT: URGE YOUR MEMBERS OF CONGRESS TO SIGN ON IN SUPPORT OF VIRAL HEPATITIS FUNDING
April 10

HCV-infected patients bury heads in sand
April 10

Cardiovascular Issues Up Mortality Rates in Patients with Advanced Fibrosis
April 10

Bristol-Myers Squibb to Present New Data on Hepatitis C and Hepatitis B Compounds at The International Liver CongressTM (ILC) 2013
April 9

New mouse viruses could aid hepatitis research
April 9

Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C
April 8

Hepatitis C spikes on Cape Cod
April 8

Device Keeps Human Liver Alive Outside Body
April 7

Canada: Report finds more people are dying from liver disease, calls for national strategy
April 6

Jury: HMO liable for $24M in Vegas hep C outbreak
April 5

Tears in court as victims of the 'largest hepatitis C outbreak in U.S. history' are awarded $24million
April 5

Daclatasvir/asunaprevir effective in difficult-to-treat HCV populations
April 5

Vertex Enters Agreement with Bristol-Myers Squibb for Phase 2 All-Oral Studies of VX-135 in Combination with Daclatasvir for the Treatment of Hepatitis C
April 5

Hepatitis C a hidden health threat: Oshawa man
April 4

Russell Morris - Russell Morris Backs Hepatitis C Campaign
April 4

Medicare patients need hepatitis C tests, coalition says
April 4

Incarceration, Marijuana Use and Suicide Attempts May Hinder Liver Transplant Eligibility
April 4

ACTION ALERT: Urge Your Members of Congress to Support Viral Hepatitis Funding In Their Appropriations Programmatic Requests
April 3

Formal HCV education improved time to therapy initiation, response
April 3

Liver diseases pose major problem in future for health care professionals: report
April 2

ChronTech's controlled clinical study of ChronVac-C® gives mixed results
April 2

HCV coinfection not predictive of kidney disease in liver transplant recipients with HIV
April 2

Congress must restore federal funding for needle exchange
April 1

Screen all psoriasis patients for hepatitis before immunosuppressive therapy
April 1

B.C. plan to wipe out hepatitis will follow HIV model
March 29

Oklahoma Dentist May Have Exposed Thousands To Disease
March 29

Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
March 28

Sofosbuvir combination shows promise in non-cirrhotic, treatment-naive HCV
March 28

A new drug shows promise of hepatitis C cure
March 28

'Sponge' Drug Shows Promise For Treating Hepatitis C
March 27

May is Hepatitis Awareness Month! Free & Low Cost Opportunities from CDC and local NGOs
March 27

Patients with HCV may deliberately skip early treatment doses when feeling well
March 27

Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients
March 26

Hepatic Encephalopathy Explored in New Film, Clinical Studies
March 26

Hyperpigmentation common adverse event of interferon-based chronic HCV therapy
March 26

A new hepatitis threat—Hepatitis E
March 25

Temporary Tattoos May Put You at Risk
March 25

Millions on Verge of Diabetes Don't Know It: CDC –with comments by Alan Franciscus
March 22

Affordable Care Act extended free preventive care to 71 million Americans with private health insurance
March 22

Better Long-Term Outcomes With Low Hep C Viral Load
March 22

Duke Clinical Research Unit to Conduct Hepatitis C Clinical Trial
March 22

Gilead And Its Competitors In The Hepatitis C Race
March 22

Statins tied to lowered liver cancer risk with hepatitis C
March 21

Report highlights weaknesses in case of health worker who exposed thousands to hepatitis C
March 21

Hepatitis C Legislative Awareness Day In Albany
March 21

Data lacking on impact of psychosocial, behavioral factors on HCV treatment response
March 21

HCV Treatment in Special Populations
March 19

Sex between monogamous heterosexuals rarely source of hepatitis C infection
March 19

Newly incarcerated have 1 percent acute hepatitis C prevalence
March 19

Roche's Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older
March 18

BioLineRx to Initiate HCV Study
March 16

Patients with HCV who failed prior therapy benefited from vaniprevir/peginterferon/ribavirin
March 16

Even moderate drinking may be risky with hepatitis C
March 15

Device keeps liver "alive" outside body in medical first
March 15

FAQ: The link between hepatitis C and liver cancer
March 15

CROI 2013: Updates on the Treatment of Hepatitis C (Video) with Liz HIghleyman
March 14

Study Shows Health Outcome in HCV Tied to Specialty Pharmacy Channel
March 14

Presidio Pharmaceuticals Announces Collaboration with Boehringer Ingelheim
March 13

Adding telaprevir improves acute hepatitis C treatment for HIV-positive men
March 12

N.Y. aims to prevent unsafe injections
March 12

Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection
March 12

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies—with Comments by Alan Franciscus
March 11

Hep C Treatment Helps Stop Cirrhosis Progression in Those Coinfected With HIV
March 11

UC research uncovers hepatitis trend
March 10

Pfizer Stops Developing Hepatitis C Drug (filibuvir), Cites Strategic Review
March 8

Sofosbuvir combination efficacious in difficult-to-treat HCV patients
March 8

CROI 2013: Sofosbuvir + Ledipasvir + Ribavirin Combo for HCV Produces 100% Sustained Response
March 8

Vic doctor jailed for giving hep C to 55
March 7

The Petri Dish: Hepatitis C: another baby boomer legacy
March 7

Roche Gets FDA Approval For Hepatitis-C Therapy Response
March 6

The Perfect Cure for Hepatitis C?
March 6

All-Oral Regimens Work in HCV
March 6

Meal consumption confounds liver stiffness measurements in patients with chronic HCV
March 5

SBNC Offering Free HIV & Hepatitis C Testing--Santa Barbara, March 11, 2013
March 5

Patient Dilemma: Treat Hepatitis C Now or Hold Out?
March 4

Studies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart HCV
March 4

Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
March 4

First interim results from a phase IIa study evaluating an all-oral regimen of Simeprevir and Sofosbuvir in prior null responder Hepatitis C patients
March 4

Week-24 Interim Analysis of the TMC435-C212 Study in HIV and HCV Co-Infected Patients
March 4

Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
March 4

Rural Hepatitis C patients receive care locally
March 4

Milk Thistle Drug May Help Control HCV Replication after Liver Transplant
March 3

FDA Hepatitis Update - Vicrelis (boceprevir) label changes
March 1

Addressing Hepatitis C Disparities in the African American Community
February 28

Help Lift the Ban on Funding of Needle Exchange
February 27

Hepatitis C testing offered at Health Fair this year
February 27

Chronic HCV linked to hypertension, congestive heart failure
February 27

Scientists are not divided over device that 'remotely detects hepatitis C'
February 27

SAMHSA Announces New Funding Announcement for Rapid Hepatitis C Screening in Drug Treatment Programs
February 26

The Hidden Costs of Health Care
February 25

Hepatitis C Outbreak Prompts Legislation
February 22

Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma, with comments by Alan Franciscus
February 22

Regulatory Application has now been filed for Simeprevir (TMC435) in Japan for the treatment of genotype 1 hepatitis C patients
February 22

Clinical Effects of Viral Relapse after Interferon Plus Ribavirin in Patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus—with Comments by Alan Franciscus
February 21

Antioxidant Improves Donated Liver Survival Rate to More Than 90%
February 21

Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study—with Comments by Alan Franciscus
February 20

New Study on Hepatitis C Drug Treatment Yields More Accurate Estimate of HCV Half-Life
February 19

An Epidemiologic Update on Hepatitis C Infection in Persons Living With or at Risk of HIV Infection, with comments by Alan Franciscus
February 19

Australians gain access to new medicines to help cure hepatitis C
February 19

Gilead 's Sofosbuvir for Hepatitis C Meets Primary Endpoint in Fourth Pivotal Phase 3 Study
February 19

Fried foods have similar impact on your liver as hepatitis
February 16

Incident anemia improved response to peginterferon, ribavirin, boceprevir in HCV patients
February 16

Vitamin A deficiency reduced response to therapy for chronic HCV
February 15

FDA Hepatitis Update - Victrelis (boceprevir) label updates
February 15

13 found positive for hepatitis after hospital tests
February 14

Researchers Study Nurses' Knowledge of HCV Transmission
February 13

Carr talks Hepatitis-C cure
February 13

Studies Point to Advent of IFN-Free Regimens for Hepatitis C Infection
February 13

Souped-Up IFN Could Improve HCV Treatment
February 13

Anemia Management in Patients with Chronic Viral Hepatitis C (February) with Comments by Alan Franciscus
February 13

Use of HCV DAAs Differs From Clinical Trials
February 13

Sounding the Alarm on a Silent Epidemic: Federal HIV/STD Advisory Group Adopts Viral Hepatitis as Priority
February 12

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting—with comments by Alan Franciscus
February 12

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype-1 Infection Response-Guided Therapy
February 11

Mericitabine improved outcomes from peginterferon/ribavirin therapy for chronic HCV
February 8

French biotech rapidly stuck on losing side of hep C revolution
February 8

Campaign targets rising Hepatitis infections
February 7

Study Identifies Liver Gene that Regulates Cholesterol and Fat Blood Levels
February 7

Chronic Hepatitis Cohort Study Sheds Light on Burden of Hepatitis B and C in U.S.
February 7

Idenix Pharmaceuticals Discontinues Development of IDX184 and IDX19368
February 5

HCV Clinical Trials: Why One Might be Right for You
February 4

Two Phase 3 Studies Results of Sofosbuvir for Hepatitis C Released
February 4

Northern Kentucky sees spike in Hepatitis C rate
February 4

Viral Hepatitis Updates from CDC
February 1

Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer
January 31

Celsion plunges 80 percent as liver cancer therapy fails trial
January 31

Chronic hepatitis C: Interferon may be harmful in re-treatment
January 30

Genotype / Subtype Distribution in the United States
January 30

Medgenics kicks off trial of hepatitis C treatment
January 30

National Hepatitis C Survey Prompts Call for All Canadian Boomers to Get Tested
January 29

Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and non-patient factors
January 29

Treatment for Hepatitis C Virus Infection in Adults [Internet]
January 28

New Interferon-free Development Program
January 28

More bad news as BioCryst ditches hepatitis C candidate
January 28

FDA approves three new drug treatments for type 2 diabetes
January 28

An Interview with Alan Franciscus of the Hepatitis C Support Project (Part 2)
January 25

Treatment response improved neurocognitive function in patients with chronic HCV
January 25

Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
January 25

The Eye of the Needle
January 24

Second NY hospital warns patients about potential HIV, hepatitis exposure from insulin pens
January 24

IDSA urges USPSTF to reconsider HCV testing recommendation
January 24

Shorter surveillance periods detected smaller HCC in patients with viral hepatitis
January 24

An Interview with Alan Franciscus of the Hepatitis C Support Project (Part 1)
January 23

Tattooing poses HCV risk
January 22

New Ways to Study HCV, Genotypes 3 and 4
January 22

Rapid pace of liver damage in recent HCV co-infection
January 21

Lower Cognitive Scores in Women With HCV/HIV Than With HIV Alone
January 21

Inuit women’s group hosts hepatitis C gathering in Kuujjuaq next week
January 18

Edmonton hospital fed newborn hepatitis C-tainted breast milk, parents allege
January 18

Online tattoo and piercing kits could be spreading Hepatitis C
January 17

'Shame' discouraging hepatitis C treatment
January 17

New Research into survival of HCV outside of the syringe
January 17

Boehringer Ingelheim enrols first patients in pivotal Phase III interferon-free hepatitis C trial programme
January 17

Needle exchanges 'can curb Hep C'
January 16

Second patient tests positive for hepatitis
January 15

Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the 'Silent Pandemic' that is Hepatitis C
January 15

Achillion Reports Interim Results on ACH-3102
January 14

Accidental Exposure: More Than 700 Patients May Have Been Exposed To HIV, Hepatitis At Buffalo VA Hospital
January 14

As Hepatitis C Sneaks Up On Baby Boomers, Treatment Options Grow
January 14

Charlotte Doctor Involved In Groundbreaking Hepatitis C Study
January 13

Water and Filters Used for Drug Injection May Transmit Hepatitis C Virus
January 13

Management of Chronic HCV in the Era of Protease Inhibitors
January 13

Decline in Available Liver Transplants Expected
January 10

Inovio Pharmaceuticals to Initiate Clinical Trial for its Hepatitis C Therapeutic Vaccine (INO-8000) Later this Year
January 9

Idenix says FDA seeks more time to review hepatitis C drug
January 9

After liver transplant for HCV, better antiviral results with cyclosporine
January 8

Study identifies promising new hepatitis C treatment
January 8

Gilead Provides Update on Hepatitis C Development Programs
January 8

Targeting Hepatitis C Treatment: The Importance of Interleukin (IL)-28
January 7

Gilead says on track with hepatitis C treatments
January 7

NIH investigators discover new gene that affects clearance of hepatitis C virus
January 7

Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors
January 7

Caxton Foundation announces the appointment as trustee of Ann Lloyd CBE
January 7

Competition affects who gets a liver transplant: study
January 6

Advocates slam delay in listing hepatitis C drugs
January 6

Interferon-Free Therapy For Hepatitis C May Become A Reality
January 4

New Pills Show Promise Against Hepatitis C
January 2

What The Health Law Will Bring In 2013
January 1

 

Older News

 

 


About Hepatitis | News Updates | Community & Support | Resource Library | About HCSP | Contact Us | Site Map | Recursos en Espaņol | Home

Hepatitis C Support Project

Š 2014 Hepatitis C Support Project

Medical  Writers' Circle
Fact Sheets